<p>We examined genetic variation associated with <a href="https://www.ncbi.nlm.nih.gov/datasets/taxonomy/33892/">BCG</a>-induced innate immune responses and susceptibility to pediatric tuberculosis (TB) disease. South African study participants were enrolled at the South African Tuberculosis Vaccine Initiative (SATVI) as part of a larger BCG vaccination study. This area has one of the highest rates of TB incidence in the world. Infants were vaccinated with BCG at birth, and a nested case-control study was performed over a 2-year prospective observation period, which resulted in 135 infant TB cases and 521 controls. Whole blood was collected from BCG vaccinated infants at 10 weeks of age. Genotyping was performed with the llumina MegaEx Beadchip, and GWAS was performed against TB disease to assess for associations between genetic variants and susceptibility to TB. In addition, a subset of infants were assessed for BCG-induced innate immune responses (N=198). For these, whole blood was stimulated with BCG or media and flow cytometry was used to measure BCG-induced <a href="https://www.ncbi.nlm.nih.gov/gene/29126">PDL1</a>, <a href="https://www.ncbi.nlm.nih.gov/gene/958">CD40</a>, and cytokine expression in myeloid (mDC) and plasmacytoid (pDC) dendritic cells, monocytes, and neutrophils. Cellular GWAS was then performed to associate genetic variants with BCG-induced immune responses.</p>

Immunogenetics of BCG Vaccination and Pediatric Tuberculosis

Description

Applying For Access

Summary